ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0813
0.00%
Brent Oil
72.72
0.00%
Bitcoin
96,857.81
-0.36%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Nutriband Inc (NTRB) Cotización

Nutriband Inc

Nutriband Inc (NTRB)

NASDAQ
4.08
-0.19
(-4.45%)
Cerrado 21 Diciembre 3:00PM
Delayed by 15 minutes
4.05
-0.03
(-0.74%)
Fuera de horario: 6:59PM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
4.08
Postura de Compra
3.90
Postura de Venta
4.71
Volume Operado de la Acción
30,327
4.02 Rango del Día 4.40
2.22 Rango de 52 semanas 9.595
Capitalización de Mercado [m]
45.313M
Precio Anterior
4.27
Precio de Apertura
4.40
Hora
10
@
4
Última hora de negociación
Volumen financiero
US$ 127,276
Precio Promedio Ponderado
4.1968
Volumen promedio (3 m)
24,731
Acciones en circulación
11,106,185
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-8.20
Beneficio por acción (BPA)
-0.49
turnover
2.09M
Beneficio neto
-5.49M

Acerca de Nutriband Inc

Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically O... Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products. Mostrar más

Sector
Ortho,prosth,surg Appl,suply
Industria
Ortho,prosth,surg Appl,suply
Sitio web
nutriband.com
Sede
Las Vegas, Nevada, USA
Fundado
-
Nutriband Inc is listed in the Ortho,prosth,surg Appl,suply sector of the NASDAQ with ticker NTRB. The last closing price for Nutriband was US$4.27. Over the last year, Nutriband shares have traded in a share price range of US$ 2.22 to US$ 9.595.

Nutriband currently has 11,106,185 shares in issue. The market capitalisation of Nutriband is US$47.42 million. Nutriband has a price to earnings ratio (PE ratio) of -8.20.

NTRB Últimas noticias

Más noticias

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

ORLANDO, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today reported its financial results for the third quarter ended October 31, 2024. The Company...

04 Diciembre 2024
GlobeNewswire Inc.

Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

ORLANDO, Fla., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (Nasdaq:NTRB)(Nasdaq:NTRBW) today announced that it will be presenting at the Noble Conference taking place December 3rd and 4th...

04 Diciembre 2024
GlobeNewswire Inc.

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

ORLANDO, Fla., Nov. 27, 2024 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today...

27 Noviembre 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

03 Septiembre 2024
Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]

26 Julio 2024
Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness

25 Julio 2024
Edgar (US Regulatory)

IBN Coverage Initiated for Nutriband Inc.

LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Nutriband Inc. (NASDAQ: NTRB), a pharmaceutical company with a specific focus on transdermal technologies, today announces it has...

25 Abril 2024
GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals

12 Febrero 2024
Edgar (US Regulatory)

Form 8-K - Current report

25 Enero 2024
Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership

23 Enero 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.155-3.659976387254.2354.773.8701370804.32997708CS
4-0.91-18.23647294594.995.043.8701294964.33339939CS
12-2.14-34.40514469456.228.493.8701247315.52425456CS
26-1.06-20.62256809345.149.5953.75316885.87773253CS
521.53602.559.5952.22332725.00495512CS
156-0.04-0.9708737864084.1212.181.532639609.12173558CS
260-1.4-25.54744525555.4812.321.533549699.11582942CS

NTRB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Nutriband?
El precio actual de las acciones de Nutriband es US$ 4.08
¿Cuántas acciones de Nutriband están en circulación?
Nutriband tiene 11,106,185 acciones en circulación
¿Cuál es la capitalización de mercado de Nutriband?
La capitalización de mercado de Nutriband es USD 47.42M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Nutriband?
Nutriband ha negociado en un rango de US$ 2.22 a US$ 9.595 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Nutriband?
El ratio precio/beneficio de Nutriband es -8.2
¿Cuál es el ratio de efectivo a ventas de Nutriband?
El ratio de efectivo a ventas de Nutriband es 21.58
¿Cuál es la moneda de reporte de Nutriband?
Nutriband presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Nutriband?
El último ingresos anual de Nutriband es USD 2.09M
¿Cuál es el último beneficio anual de Nutriband?
El último beneficio anual de Nutriband es USD -5.49M
¿Cuál es la dirección registrada de Nutriband?
La dirección registrada de Nutriband es 3773 HOWARD HUGHES PARKWAY, SUITE 500S, LAS VEGAS, NEVADA, 89169 6014
¿Cuál es la dirección del sitio web de Nutriband?
La dirección del sitio web de Nutriband es nutriband.com
¿En qué sector industrial opera Nutriband?
Nutriband opera en el sector ORTHO,PROSTH,SURG APPL,SUPLY

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
MYSZMy Size Inc
US$ 4.2001
(211.12%)
121.03M
NVNINVNI Group Ltd
US$ 8.26
(209.36%)
78.06M
TPICTPI Composites Inc
US$ 2.45
(100.82%)
34M
ICGIntchains Group Ltd
US$ 8.77
(88.60%)
527.94k
HSDTHelius Medical Technologies Inc
US$ 0.884851
(84.34%)
121.95M
CYNCYNGN Inc
US$ 0.4603
(-71.41%)
27.91M
MTEMMolecular Templates Inc
US$ 0.1502
(-57.09%)
8.75M
PRFXPainReform Ltd
US$ 5.15
(-53.85%)
2.94M
GALTGalectin Therapeutics Inc
US$ 1.03
(-48.50%)
9.27M
BCABBioAtla Inc
US$ 0.6923
(-41.82%)
6.25M
EDBLEdible Garden AG Inc
US$ 0.24
(65.06%)
354.33M
NVDANVIDIA Corporation
US$ 134.70
(3.08%)
310.19M
APTOAptose Biosciences Inc
US$ 0.28
(64.51%)
306.25M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0.606999
(6.49%)
293.22M
PLTRPalantir Technologies Inc
US$ 80.55
(8.54%)
281.23M

NTRB Discussion

Ver más
Seriously folks Seriously folks 5 meses hace
Must have been an interesting webinar….double the volume and down 8%.
👍️0
Monksdream Monksdream 5 meses hace
NTRB new 52 week high
👍️0
Seriously folks Seriously folks 7 meses hace
Now I’m told “it’ll “ happen 4q 2025….
More baloney….
👍️0
Seriously folks Seriously folks 7 meses hace
Now I’m told “it’ll “ happen 4q 2025….
More baloney….
👍️0
Seriously folks Seriously folks 7 meses hace
Typical ntrb day…
👍️0
Awl416 Awl416 7 meses hace
Solid day
👍️0
Monksdream Monksdream 8 meses hace
Wowser! I happen to agree with you.
👍️0
ZigZag1 ZigZag1 8 meses hace
It’s under $5 for a reason. Management is just using this company as a lifestyle paycheck.
👍️0
Monksdream Monksdream 8 meses hace
NTRB under $5

👍️0
Monksdream Monksdream 9 meses hace
NTRB under $5
👍️0
glenn1919 glenn1919 9 meses hace
NTRB................................https://stockcharts.com/h-sc/ui?s=NTRB&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 9 meses hace
NTRB....MONSTER
👍️0
TrendTrade2016 TrendTrade2016 9 meses hace
NTRB...GAPPING INTO OPEN FOR THE SELL
👍️0
glenn1919 glenn1919 9 meses hace
NTRB...................................https://stockcharts.com/h-sc/ui?s=NTRB&p=W&b=5&g=0&id=p86431144783
👍️0
TrendTrade2016 TrendTrade2016 9 meses hace
NTRB....PRE TO OPEN BEAST
👍️0
Inve$tor77 Inve$tor77 1 año hace
$NTRB 2.95. Nice buys.
👍️0
ZigZag1 ZigZag1 1 año hace
This will be at a $1.50 by the end of the week. Management sure sold me on this one!
👍️0
ZigZag1 ZigZag1 1 año hace
You’d think it price would reflect news like this. They have to get rid of the word “fentanyl”. It’s so toxic. It’s right up there with ephedrine and OxyContin.
👍️0
Inve$tor77 Inve$tor77 1 año hace
Nice news!

https://www.accesswire.com/785775/nutriband-announces-issuance-of-us-patent-for-transdermal-abuse-deterrent-technology
👍️0
ZigZag1 ZigZag1 1 año hace
I sold everything, I just check back from time to time. I think they are now just using their money for salaries. Their model has the word “fentanyl” in it which is about as toxic as the word “OxyContin”.
👍️0
Seriously folks Seriously folks 1 año hace
What’s going on with this stock?
👍️0
McMagyar McMagyar 1 año hace
Ollie Ollie unkenfraz
👍️0
McMagyar McMagyar 1 año hace
What lurks behind the curtain!
👍️0
stock1ace1 stock1ace1 1 año hace
Registration withdraw low float
👍️0
Monksdream Monksdream 1 año hace
NTRB dead cat and the down trend resumes?
👍️0
Inve$tor77 Inve$tor77 1 año hace
What’s with the huge selling? Seems like big ask
👍️0
Inve$tor77 Inve$tor77 1 año hace
Bid and ask tight. Volume coming in.
👍️0
Inve$tor77 Inve$tor77 1 año hace
Agreed. Once the selling stop perhaps it will rebound back .
👍️0
ZigZag1 ZigZag1 1 año hace
It could. But being out of money is going to make things tough. They definitely need something good to happen for this to pop.
👍️0
Inve$tor77 Inve$tor77 1 año hace
I’m not sure it’s going to hit that low before a nice bounce back. It’s still a low float stock.
👍️0
ZigZag1 ZigZag1 1 año hace
I personally see it at $1. Their revenue comes from k tape that you can get off of Amazon for $5. Their hope is this fentanyl patch. But even if they get approval? I don’t see many Drs wanting to prescribe it, nor patients wanting it. Let’s put it this way; if a dr asked you if you wanted traditional pain meds or a fentanyl patch; what would you want?
👍️0
Inve$tor77 Inve$tor77 1 año hace
Where’s bottom? Should be close for a bounce hopefully.
👍️0
ZigZag1 ZigZag1 1 año hace
It’s like 7.5m outstanding, but now doing an offering of $4m with a market cap of $15m, just simply means they are out of money. This isn’t looking good. I just wish they would change the name to something like “drug deterrent patch” or something. Who would want to keep an investment in fentanyl? That’s a word right up there with OxyContin???
👍️0
Inve$tor77 Inve$tor77 1 año hace
Wasn’t there an offering for $4 mill minus underwriting fees?
I don’t remember the volume being that high. Isn’t that around 1.5 million shares sold.

“Our common stock is traded on the NASDAQ Capital Market under the symbol “NTRB. On June 22, 2023, the last reported sale price of our common stock was $2.48 per share.”
👍️0
ZigZag1 ZigZag1 1 año hace
Dang, they get a patent approved and now it’s tanking. This will give you an idea of how solid their model is.
👍️0
ZigZag1 ZigZag1 1 año hace
Why so much volume today?
👍️0
Inve$tor77 Inve$tor77 2 años hace
New 52 week lows geez. What’s going on?
👍️0
Inve$tor77 Inve$tor77 2 años hace
$2.50s. Looking for a nice bounce possibly . Float is tiny
👍️0
ZigZag1 ZigZag1 2 años hace
I’m not sure their model has the capability of meaningful good news. Anything with the fentanyl in it, proves to be an uphill battle.
👍️0
Inve$tor77 Inve$tor77 2 años hace
With any good news or buying pressure this can take off nicely. Very thin float.
👍️0
Inve$tor77 Inve$tor77 2 años hace
Nice bounce recovery from lows. When good news hits looking forward to a big climb. I saw they filed for a small offering a couple of weeks ago. I’m surprised they did it at this low price.
👍️0
ZigZag1 ZigZag1 2 años hace
Yes they are. But I think it’s going to be an up-hill battle trying to get anything approved with the word “Fentanyl” in it. Talk about FDA scrutiny!
👍️0
Inve$tor77 Inve$tor77 2 años hace
Does anyone know if they are still waiting on FDA approval ?
👍️0
McMagyar McMagyar 2 años hace
Nice day
👍️0
Seriously folks Seriously folks 2 años hace
It looks like this might be turning around….
👍️0
McMagyar McMagyar 3 años hace
Entrepreneurial spirit isn’t dead
Nutriband full steam ahead
👍️0
McMagyar McMagyar 3 años hace
I don’t think market is giving the 3m agreement enough value.they may have a few surprises coming our way
👍️0
Seriously folks Seriously folks 3 años hace
Still heading the wrong direction!
👍️0
Seriously folks Seriously folks 3 años hace
What a disappointment……
👍️0
StocksNcash StocksNcash 3 años hace
I dumped it garbage
👍️0

Su Consulta Reciente

NASDAQ
NTRB
Nutriband
NASDAQ
CUTR
Cutera
LSE
7TJS
Adecco Int 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados